Peer-reviewedCC BYJPGN reports
Acneiform eruption associated with Janus kinase inhibitors in pediatric inflammatory bowel disease: Case series and clinical management guidance
- 1UCSF Benioff Children's Hospitals Oakland
- 2UCSF and UCSF Benioff Children's Hospitals
- 3UCSF Benioff Children's Hospitals
Related
- IL-17 Inhibitor-Associated New Onset Inflammatory Bowel Disease: Clinical Presentation and Management: A Report of Two Cases
- Case Report: Hepatic inflammatory myofibroblastic tumor versus hepatic inflammatory pseudotumor in pediatric patients
- Commentary: Hemophagocytic lymphohistiocytosis induced by immune checkpoint inhibitors: observations and proposed clinical management
- Transient Post-infectious Multisystem Inflammatory Overlap Presentation in a Pediatric Patient With Neurological, Hepatic, Gastrointestinal, and Autoimmune Manifestations: A Rare Case From Azerbaijan
- SGLT2 inhibitors as a strategy for volume management in peritoneal dialysis: a case series
BibTeX
@article{tran2026acneiform,
title = {{Acneiform eruption associated with Janus kinase inhibitors in pediatric inflammatory bowel disease: Case series and clinical management guidance}},
author = {Tina H. Tran and Daniel Park and Regina‐Celeste Ahmad and Malika Goel and Sofia Verstraete and Sabina Ali},
journal = {JPGN reports},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13656293},
note = {CC BY},
}
RIS
TY - JOUR
TI - Acneiform eruption associated with Janus kinase inhibitors in pediatric inflammatory bowel disease: Case series and clinical management guidance
AU - Tina H. Tran
AU - Daniel Park
AU - Regina‐Celeste Ahmad
AU - Malika Goel
AU - Sofia Verstraete
AU - Sabina Ali
PY - 2026
DA - 2026/10/12
JO - JPGN reports
UR - https://europepmc.org/article/PMC/PMC13656293
SN - 2691-171X
ER -